Studies have shown that BACE1 concentration and activity are increased in patients with AD, as well as in subjects with MCI (prodromal AD), as compared to controls.[40, 41] In addition, the ApoE-ε4 genotype has been associated with increased BACE 1 activity in both AD and MCI subjects.[42]. Here, BACE1 is linked to Alzheimer disease.